Healthcare


 UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%

UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%

October 15, 2021 01:31 AM AEDT| By Ipsita Sarkar

Highlights UnitedHealth Group (NYSE: UNH) declared third-quarter results on Thursday. The group served 146 million people across its businesses as of September 30, 2021. UNH posted revenue of US$72.3 billion and 23.5% return on equity in the t.....

 Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval

Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval

October 13, 2021 08:00 AM AEDT| By Ipsita Sarkar

Highlights Nutriband Inc. (NASDAQ: NTRB) stock jumped on securing a lucrative manufacturing deal with San Diego-based Diomics for its Diocheck™ technology. Protara Therapeutics, Inc. (NASDAQ: TARA) climbed 11.41% after receiving FDA clear.....

 CLOV, ADMS stocks up on rating upgrade, purchase deal

CLOV, ADMS stocks up on rating upgrade, purchase deal

October 12, 2021 05:10 AM AEDT| By Ipsita Sarkar

Highlights Stocks of Clover Health Investments, Corp. (NASDAQ: CLOV) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) were gaining traction on Monday. The Centers for Medicare and Medicaid Services (CMS) upgraded the CLOV stock to a 3.5-star rat.....

 ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news

ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news

October 09, 2021 03:18 AM AEDT| By Ipsita Sarkar

Highlights FDA has approved ChemoCentryx's drug Avacopan, to be sold under the brand name Tavneos. A Duke University study showed Vaxart's oral drug is more effective in reducing SARS-CoV-2 transmission.  Vaxart, Inc. (NASDAQ: VXRT) stock.....

 Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal

Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal

October 07, 2021 09:29 AM AEDT| By Sanjeeb Baruah

Highlights Voyager Therapeutics, Inc. (NASDAQ: VYGR) sealed a license option deal with Pfizer worth around US$630 million. Pfizer may exercise the option to use Voyager’s RNA-driven TRACERTM screening technology for developing its gene th.....

 Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks

Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks

October 06, 2021 06:34 AM AEDT| By Team Kalkine Media

Highlights Ocugen, Inc. (NASDAQ: OCGN) has entered into a development and supply agreement with Bharat Biotech for a Covid-19 vaccine candidate. Aditxt, Inc. (NASDAQ: ADTX) has entered into a transaction agreement for acquiring a subsidiary of .....

 Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval

Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval

October 05, 2021 10:12 AM AEDT| By Team Kalkine Media

Highlights Xenon Pharmaceuticals Inc. (NASDAQ: XENE) achieved positive topline results from phase-2b clinical trials of‘XEN1101’ for treating focal epilepsy.  OpGen, Inc. (NASDAQ: OPGN) got 510(k) received FDA clearance to mark.....

 ALZN & AEZS: Two trending biotechnology stocks on Friday

ALZN & AEZS: Two trending biotechnology stocks on Friday

October 02, 2021 03:56 AM AEST| By Ipsita Sarkar

Highlights Aeterna Zentaris Inc. (NASDAQ: AEZS) develops diagnostic and therapeutic tests. Alzamend Neuro, Inc. (NASDAQ: ALZN) develops treatment for neurodegenerative diseases and psychiatric disorders.  Aeterna has been placed on NASDAQ.....

 Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today

Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today

October 01, 2021 06:48 AM AEST| By Team Kalkine Media

Highlights Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) stocks surged 11.24 percent to US$35.74 on September 30. Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) jumped 7.97 percent to US$5.42 at 1.50 pm on Thursday. CPRX received a favorable court .....

 Why did Moderna (MRNA), Altimmune (ALT) stocks nosedive today?

Why did Moderna (MRNA), Altimmune (ALT) stocks nosedive today?

September 29, 2021 09:27 AM AEST| By Sanjeeb Baruah

Highlights Altimmune, Inc. (Nasdaq: ALT) stocks fell despite positive results from the clinical trial of its medicine for obese people. Moderna, Inc. (Nasdaq: MRNA) stock declined after recent comments from CEO Stéphane Bancel on the pan.....

 Explore seven healthcare stocks that are under US$50

Explore seven healthcare stocks that are under US$50

September 29, 2021 05:59 AM AEST| By Sanjeeb Baruah

Highlights Halozyme Therapeutics’ (NASDAQ: HALO) GAAP net income was US$91.5 million in Q2, 2021, compared to US$25.8 million in Q2, 2020. Adaptive Biotechnologies Corporation’s (Nasdaq: ADPT) revenue for Q2, 2021, was US$38.5 milli.....

 ZIVO, VTVT & APOP: Three trending healthcare stocks on Friday

ZIVO, VTVT & APOP: Three trending healthcare stocks on Friday

September 25, 2021 10:40 AM AEST| By Team Kalkine Media

Highlight Zivo Biosciences Inc (Nasdaq: ZIVO) stocks soared by 74.78% on Thursday. Cellect Biotechnology Ltd (Nasdaq: APOP) stock fell 20.712% at 1 pm ET. vTv Therapeutics Inc. (Nasdaq: VTVT) stock rose 4.52 percent a day after the company ann.....

 MEDIROM (MRM) stock surged 73%, Eargo (EAR) tanked 68% on Thursday

MEDIROM (MRM) stock surged 73%, Eargo (EAR) tanked 68% on Thursday

September 24, 2021 09:59 AM AEST| By Team Kalkine Media

Highlights MEDIROM Healthcare Technologies Inc (NASDAQ: MRM) agreed to acquire all the shares of Japanese hair salon operator ZACC Kabushiki Kaisha.  Eargo, Inc. (NASDAQ: EAR) stock tanked nearly 68% on Thursday on the news of a .....

 ONTX stock dives 16%, DVAX stock in green after clinical data

ONTX stock dives 16%, DVAX stock in green after clinical data

September 24, 2021 03:44 AM AEST| By Ipsita Sarkar

Highlights Onconova Therapeutics, Inc. (ONTX) stock shot up nearly 29% to close at US$6.3 on Sep 22. But it was down nearly 16% at 10.40 am ET on Thursday.   Dynavax Technologies Corporation (DVAX) stock is close to its 52-week high o.....

 Pfizer-BioNTech covid vaccine for 5-11 years old shows positive results

Pfizer-BioNTech covid vaccine for 5-11 years old shows positive results

September 22, 2021 09:29 AM AEST| By Sanjeeb Baruah

The Pfizer-BioNTech Covid-19 vaccine Comirnaty has been authorized for use on children aged 12 in the US and several other countries, the companies said. Also, on Sep 20, Pfizer Inc and BioNTech announced the positive results from phase 2 and 3 tr.....

 Why did NanoViricides (NNVC), ReWalk (RWLK) stocks skyrocket Tuesday?

Why did NanoViricides (NNVC), ReWalk (RWLK) stocks skyrocket Tuesday?

September 22, 2021 08:26 AM AEST| By Sanjeeb Baruah

Highlights NanoViricides, Inc. (AMEX: NNVC) was up 65.45% at 3:18 pm ET, with a trading volume of 89,899,376. ReWalk Robotics Ltd. (RWLK) rose 93.46% at 3:18 pm ET, with a share volume of 264,762,923. NanoViricides stock rose 114.29%, and ReWa.....

 ZIVO & EDSA: Two trending healthcare stocks under US$10

ZIVO & EDSA: Two trending healthcare stocks under US$10

September 21, 2021 03:26 AM AEST| By Ipsita Sarkar

Highlights ZIVO stock traded up 146.79% at 11:01 am ET on Monday. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 33.49% on Monday, boosted by positive results from its clinical study for a covid drug. However, ZIVO was down 38.58% year-to-date, and.....

 SDC, ABCL & BGNE: Three healthcare stocks swim in green on Friday

SDC, ABCL & BGNE: Three healthcare stocks swim in green on Friday

September 18, 2021 03:11 AM AEST| By Ipsita Sarkar

Highlights The revenue of SmileDirectClub (NASDAQ: SDC) increased by 62.7% YoY in Q2, FY21. AbCellera Biologics (NASDAQ: ABCL) gets FDA approval for the bamlanivimab drug. FDA also grants accelerated approval for BeiGene’s (NASDAQ: BGNE).....

 Why are Ocugen (OCGN), BioNTech (BNTX) stocks in focus?

Why are Ocugen (OCGN), BioNTech (BNTX) stocks in focus?

September 14, 2021 10:24 AM AEST| By Team Kalkine Media

Highlights Ocugen, Inc. (NASDAQ: OCGN) had cash, cash equivalents, and restricted cash of US$115.8 million in Q2, FY21. The OCGN stock surged 132.9 percent YTD. BioNTech SE (NASDAQ: BNTX) reported a net profit of €2.78 billion in Q2, FY21.....

 Top five biotechnology stocks to explore that are under US$100

Top five biotechnology stocks to explore that are under US$100

September 09, 2021 09:40 AM AEST| By Sanjeeb Baruah

Highlights Gilead Sciences, Inc’s (NASDAQ: GILD) dividend yield is 3.95%; the stock gained 23.38% YTD. Celldex Therapeutics, Inc. (NASDAQ: CLDX) stock rose 215% YTD. It closed at US$55.19 on Sep 7. Avid Bioservices, Inc’s (NASDAQ: .....

Recent Articles






Investing Tips

Previous Next